🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 4

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 4 of 20
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Mar 10, 2024 at 12:16 AM#16
roxy_nash said:
TrialTracker_MD said: ...regarding the trial evidence...

Same pattern here, and in the same order. Nothing to add that would improve it.

2 0wanda_boise, NurseAsh_DET
Reply Quote Save Share Report
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Mar 11, 2024 at 11:24 PM#17
DoseLogDan said:
Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to: Point estimate (HR/RR/OR) —…

This is exactly what I could not find anywhere else.

Last edited: Mar 12, 2024 at 4:24 AM
3 1lucas_SP_BR, lisa_labSD, adam_van
Reply Quote Save Share Report
Dr.EM_Chicago
Member
567
2,567
May 2024
Chicago, IL
Mar 13, 2024 at 10:31 PM#18

Adding the clinical framing, because it changes how the question reads. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

Happy to go further on any of that.

4 2Dr.ReproEndo, lucas_SP_BR, lisa_labSD and 1 other
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
LondonLisa
Member
912
3,456
Mar 2024
London, UK
Mar 15, 2024 at 9:37 PM#19
Dr.EM_Chicago said:
The mechanism and the magnitude are separate questions.

This matches mine closely enough to be worth saying so out loud. The detail I would add is minor and it is already implied above.

Last edited: Mar 15, 2024 at 11:37 PM
5 3JenPlateau, SallyK_inj, CryptoCarl and 2 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 17, 2024 at 8:42 PM#20

Moderator note: the sourcing question belongs in the vendor section and has been split out. Tagging this one for the weekly digest.

Last edited: Mar 18, 2024 at 12:42 AM
27 0PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 24 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register